Prescription drug spending surges amid market forces Posted on March 29, 2016 by henrykotula Posted in Uncategorized Tagged ACA, Cancer Drugs, Chronic Hepatitis C, Compounded Medications, FDA, Generic Drugs, Hepatitis C Drugs, Medicaid Expansion, Non-Orphan Drugs, Orphan Drug Act, Orphan Drugs, PCSK9-inhibitors, Prescription Drug Spending, Specialty Medications, Ultra-Orphan Drugs Leave a comment http://managedhealthcareexecutive.modernmedicine.com/managed-healthcare-executive/news/prescription-drug-spending-surges-amid-market-forces?cfcache=true Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...
California Doles Out Millions to Insurers for Hepatitis C Drugs Posted on January 28, 2016 by henrykotula Posted in Uncategorized Tagged Health Policy, Hepatitis C Drugs, Medicaid, Prescription Drug Prices Leave a comment http://ww2.kqed.org/stateofhealth/2016/01/27/california-doles-out-millions-to-insurers-for-hepatitis-c-drugs/ ‘Dollars that were intended for a wide array of medical services started being gobbled up by just one drug.’Charles Bacchi, California Association of Health Plans Share this: Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook Click to share on LinkedIn (Opens in new window) LinkedIn Like Loading...